Potential sustained benefits of early targeted panretinal photocoagulation in combination with anti-VEGF in macular edema secondary to retinal vein occlusion: 48-month results of a retrospective comparative study
The IVL group exhibited a trend toward better treatment response, particularly in patients with severe retinal ischemia, though findings were not statistically significant. Baseline IsI quantification is recommended for optimal RVO management.
Authors
- A. Kilani (ORCID: https://orcid.org/0000-0003-4134-091X)
- Christian Enders (ORCID: https://orcid.org/0000-0003-3922-3765)
- Denise Vogt (ORCID: https://orcid.org/0000-0002-1032-6675)
- Benjamin Mayer (ORCID: https://orcid.org/0000-0003-1042-9006)
- Efstathios Vounotrypidis (ORCID: https://orcid.org/0000-0002-9833-2200)
- Armin Wolf (ORCID: https://orcid.org/0000-0002-6991-2214)
- Almut Bindewald-Wittich (ORCID: https://orcid.org/0000-0002-8151-3953)
- Koray Bayhan
Institutions
- Universität Ulm (DE)
- University Hospital Ulm (DE)
- Garmisch-Partenkirchen Medical Center (DE)
Publication Details
- Journal
- BMC Ophthalmology
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1186/s12886-025-04496-9
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00